Prognostic significance of progesterone receptor in hormonal receptor-positive breast cancer: Association with endocrine resistance

被引：0
|
作者：
Bae, S. Y. [1 ]
Lee, S. K. [1 ]
Lee, J. H. [1 ]
Lee, H. [1 ]
Kim, M. [1 ]
Kim, J. [1 ]
Kil, W. H. [1 ]
Lee, J. E. [1 ]
Nam, S. J. [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P5-09-17
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-09-17
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The prognostic role of progesterone receptor in patients with rapidly proliferating, hormone receptor-positive early breast cancer.
    Bravaccini, Sara
    Bronte, Giuseppe
    Scarpi, Emanuela
    Ravaioli, Sara
    Tumedei, Maria Maddalena
    Maltoni, Roberta
    Puccetti, Maurizio
    Mangia, Anita
    Amadori, Dino
    Rocca, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] Progesterone receptor/IRS-1 cooperation promotes stem cell outgrowth and endocrine resistance in estrogen receptor-positive luminal breast cancer
    Dwyer, Amy R.
    Sachdev, Deepali
    Lange, Carol A.
    CANCER RESEARCH, 2018, 78 (13)
  • [23] Estrogen Receptor-Positive Breast Cancer: Exploiting Signaling Pathways Implicated in Endocrine Resistance
    Brufsky, Adam M.
    Dickler, Maura N.
    ONCOLOGIST, 2018, 23 (05): : 528 - 539
  • [24] Detection of spliceomic signatures for predicting endocrine resistance in estrogen receptor-positive breast cancer
    Lee, H. -B.
    Kim, M.
    Kang, Y. -J.
    Lee, E. -S.
    Rhu, J.
    Noh, D. -Y.
    Moon, H. -G.
    Kim, S.
    Han, W.
    BREAST, 2017, 32 : S40 - S41
  • [25] Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancer
    Jones, Veronica
    Yin, Hongwei Holly
    Yuan, Yate-Ching
    Wang, Yongzhe
    Li, Sierra Min
    Aljaber, Dana
    Sanchez, Angelica
    Quinones, Christine
    Schmolze, Dan
    Yuan, Yuan
    Mortimer, Joanne
    Yee, Lisa
    Kruper, Laura
    Jovanovic-Talisman, Tijana
    Tomsic, Jerneja
    Sanchez, Nancy
    Chavez, Tanya
    O'Regan, Ruth M.
    Khan, Qamar J.
    Davis, Melissa
    Kalinsky, Kevin
    Meisel, Jane
    Kittles, Rick
    Rodriguez-Rodriguez, Lorna
    Seewaldt, Victoria
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [26] The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer
    Yuan, Jie
    Yang, Li
    Li, Zhi
    Zhang, Hua
    Wang, Qun
    Huang, Jun
    Wang, Bei
    Mohan, Chakrabhavi Dhananjaya
    Sethi, Gautam
    Wang, Geng
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [27] Novel Strategies in Hormone Receptor-Positive Advanced Breast Cancer: Overcoming Endocrine Resistance
    Garrido-Castro A.C.
    Metzger-Filho O.
    Current Breast Cancer Reports, 2016, 8 (4) : 193 - 205
  • [28] Endocrine Therapy in Premenopausal Hormone Receptor-Positive Breast Cancer
    Tevaarwerk, Amye J.
    Wisinski, Kari B.
    O'Regan, Ruth M.
    JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (11) : 1148 - +
  • [29] The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer
    Downey, C. L.
    Simpkins, S. A.
    White, J.
    Holliday, D. L.
    Jones, J. L.
    Jordan, L. B.
    Kulka, J.
    Pollock, S.
    Rajan, S. S.
    Thygesen, H. H.
    Hanby, A. M.
    Speirs, V.
    BRITISH JOURNAL OF CANCER, 2014, 110 (07) : 1744 - 1747
  • [30] The prognostic significance of tumou-stroma ratio in oestrogen receptor-positive breast cancer
    Krishnamurthy, S.
    Breast Diseases, 2015, 26 (01): : 53 - 55
12345